WBA Stock Climbs On Plan To Close Thousands of Stores: Retail Is Betting On A Comeback

The company’s U.S. healthcare and international businesses are expected to grow, while its U.S. retail pharmacy division is projected to face continued challenges.
Walgreens announced a three-year “footprint optimization program” targeting approximately 1,200 store closures.
Walgreens announced a three-year “footprint optimization program” targeting approximately 1,200 store closures. Photo via Mike Mozart on Flickr
Profile Image
Ramakrishnan M·Stocktwits
Updated Mar 05, 2026   |   2:29 PM EST
Share
·
Add us onAdd us on Google
Loading...Loading...Loading...Loading...Loading...Loading...Loading...Loading...Loading...Loading...Loading...Loading...Loading...Loading...Loading...Loading...

Shares of Walgreens Boots Alliance Inc. ($WBA) surged more than 5% pre-market Tuesday after the company reported better-than-expected earnings and revealed a significant store closure plan.

Walgreens earned $0.39 per share on an adjusted basis in its fiscal fourth quarter, exceeding analysts’ average estimate of $0.36 per share.

The company’s revenue climbed 6% year-over-year to $37.5 billion, topping expectations of $35.8 billion.

Read Next
Loading...
Loading...

Advertisement|Remove ads.

In addition to its earnings beat, Walgreens announced a three-year “footprint optimization program” targeting approximately 1,200 store closures — about 14% of its U.S. locations — including 500 closures planned for fiscal 2025.

The company believes this move will be immediately accretive to adjusted earnings per share (EPS) and free cash flow.

“Fiscal 2025 will be an important rebasing year as we advance our strategy to drive value creation. This turnaround will take time, but we are confident it will yield significant financial and consumer benefits over the long term,” said CEO Tim Wentworth.

Advertisement|Remove ads.

Walgreens provided a fiscal 2025 earnings forecast of $1.40 to $1.80 per share, against a consensus estimate of $1.72.

For full-year sales, the company expects revenue between $147 billion and $151 billion, aligning with analysts’ expectations of $147.6 billion.

The company’s U.S. healthcare and international businesses are expected to grow, while its U.S. retail pharmacy division is projected to face continued challenges.

Advertisement|Remove ads.

WBA sentiment and message volume Oct 15 premarket.png
WBA sentiment and message volume Oct 15 premarket as of 8:45 am ET | source: Stocktwits

On Stocktwits, retail sentiment for WBA turned ‘bullish’ in pre-market trading, with a noticeable increase in message volume.

Advertisement|Remove ads.

Earlier, CEO Wentworth had warned that headwinds would persist into 2025 as the retail pharmacy division faces stiff competition from e-commerce giants like Amazon and discount retailers such as Dollar General and Costco.

WBA stock is still down more than 66% year-to-date.

Read next: UnitedHealth Group’s Stock Falls Pre-Market As Higher Medical Costs Eat Into Profits: Here’s How Retail Is Reacting

Advertisement|Remove ads.

Comments
Share your thoughts...

Comments posted here will also appear on symbol pages.

Follow on Google News
Read about our editorial guidelines and ethics policy

Advertisement|Remove ads.